Tag: dual antiplatelet therapy
Dual antiplatelet therapy linked to better post-TCAR outcomes versus other drug...
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid artery...
Similar complication rates observed following DAPT discontinuation within and past 90...
The duration of dual antiplatelet therapy (DAPT), either 30–90 days or more than 90 days, following implantation of a flow diverter in cerebral aneurysm...
ESMINT 2021: COATING study “badly needed” to assess surface modification of...
This year’s Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021; 8–10 September, Nice, France and virtual) saw details of the...
